|
1 |
|
Equity and commissioning - Richard Sullivan |
Session 4: Equity and commissioning - Richard Sullivan |
Mark Sheehan, Richard Sullivan |
19 Jan 2017 |
|
2 |
|
Equity and commissioning - Muir Gray |
Session 4: Equity and commissioning - Muir Gray |
Muir Gray, Mark Sheehan |
19 Jan 2017 |
|
3 |
|
Data sharing and participation - Jonathan Montgomery |
Session 3: Data sharing and participation - Jonathan Montgomery |
Ingrid Slade, Jonathan Montgomery |
19 Jan 2017 |
|
4 |
|
Data sharing and participation - Anna Middleton |
Session 3: Data sharing and participation - Anna Middleton |
Ingrid Slade, Anna Middleton |
19 Jan 2017 |
|
5 |
|
Data sharing and participation - Mark Lawler |
Session 3: Data sharing and participation - Mark Lawler |
Mark Lawler, Ingrid Slade |
19 Jan 2017 |
|
6 |
|
The human person and the communication of risk - Sian Rees |
Session 2: The human person and the communication of risk - Sian Rees |
Rob Horne, Sian Rees |
19 Jan 2017 |
|
7 |
|
The human person and the communication of risk - Alastair Kent |
Session 2: The human person and the communication of risk - Alastair Kent |
Rob Horne, Alastair Kent |
19 Jan 2017 |
|
8 |
|
The human person and the communication of risk - Joshua Hordern |
Session 2: The human person and the communication of risk - Joshua Hordern |
Joshua Hordern, Rob Horne |
19 Jan 2017 |
|
9 |
|
The promise and the hype of 'personalised medicine' - John Tooke |
Session 1: The promise and the hype of 'personalised medicine' - John Tooke |
Joshua Hordern, John Tooke |
19 Jan 2017 |
|
10 |
|
The promise and the hype of 'personalised medicine' - Steve Sturdy |
Session 1: The promise and the hype of 'personalised medicine' - Steve Sturdy |
Steve Sturdy, Joshua Horden |
19 Jan 2017 |
|
11 |
|
The promise and the hype of 'personalised medicine' - Tim Maughan |
Session 1: The promise and the hype of 'personalised medicine' - Tim Maughan |
Tim Maughan, Joshua Hordern |
19 Jan 2017 |
|
12 |
|
Highlights of Personalised Medicine |
Highlights of Personalised Medicine: the promise, the hype and the pitfalls |
Alastair Kent, Anna Middleton, Marion Lynch, Muir Gray |
19 Jan 2017 |
|
13 |
|
Personalised Medicine, interview with Jonathan Montgomery |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Jonathan Montgomery |
Jonathan Montgomery |
18 Jan 2017 |
|
14 |
|
Personalised Medicine, interview with Anna Middleton |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Anna Middleton |
Anna Middleton |
18 Jan 2017 |
|
15 |
|
Personalised Medicine, interview with Marion Lynch |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Marion Lynch |
Marion Lynch |
18 Jan 2017 |
|
16 |
|
Personalised Medicine, interview with Mark Lawler |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Mark Lawler |
Mark Lawler |
18 Jan 2017 |
|
17 |
|
Personalised Medicine, interview with Alastair Kent |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Alastair Kent |
Alastair Kent |
18 Jan 2017 |
|
18 |
|
Personalised Medicine, interview with Rick Kaplan |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Rick Kaplan |
Rick Kaplan |
18 Jan 2017 |
|
19 |
|
Personalised Medicine, interview with Muir Gray |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Muir Gray |
Muir Gray |
18 Jan 2017 |
|
20 |
|
How can massive genetic studies help us prevent and treat diabetes? |
Any pair of individuals will share 99.9% of their DNA. But that 0.1% difference can tell us a huge amount about the causes of disease and how we can treat them. Find out more about the genetics that underpin type 2 diabetes. |
Mark McCarthy |
11 Jul 2016 |
|
21 |
Creative Commons |
Repairing DNA damage |
Dr Ross Chapman studies the molecular events triggered by DNA damage detection, and why defects in these events lead to immune deficiency and cancer in humans. |
Ross Chapman |
28 Apr 2016 |
|
22 |
Creative Commons |
Repairing DNA damage |
Dr Ross Chapman studies the molecular events triggered by DNA damage detection, and why defects in these events lead to immune deficiency and cancer in humans. |
Ross Chapman |
28 Apr 2016 |
|
23 |
|
'Explosions' part 3 - Health and Big Data |
Professor Gil McVean explains what Big Data is and how it can be used to better understand and treat complex conditions, such as heart disease and dementia. |
Gil McVean |
30 Mar 2015 |
